Global Danoprevir Sodium Market Growth 2026-2032
The global Danoprevir Sodium market size is predicted to grow from US$ 1761 million in 2025 to US$ 230 million in 2032; it is expected to grow at a CAGR of 19.7% from 2026 to 2032.
In 2025, global Danoprevir Sodium production reached approximately 23,000 units.Danoprevir Sodium (brand name: Ganovo), independently developed by Ascletis Pharma, is China?s first domestically originated Class 1 chemical anti?hepatitis C virus (HCV) drug. Classified as a new?generation NS3/4A protease inhibitor among direct?acting antivirals (DAAs), it is an achievement of the national Major New Drug Creation Project. Approved by the NMPA in June 2018, it is indicated for the targeted antiviral treatment of chronic hepatitis C.
Danoprevir Sodium is an NS3/4A protease inhibitor targeting hepatitis C virus (HCV), typically used in combination with other direct-acting antivirals (DAAs), and has an established application base in China?s HCV antiviral treatment market. With the continued advancement of the national ?hepatitis C elimination? strategy and improvements in screening and diagnosis rates, treatment demand is being progressively released, providing a stable market opportunity for this drug.
From a competitive landscape perspective, pan-genotypic DAA regimens centered on Sofosbuvir, along with imported originator products, still dominate the market. However, danoprevir sodium, leveraging its domestic R&D background, pricing advantages, and value in specific combination regimens, demonstrates a certain level of competitiveness in selected patient populations.
On the policy side, national reimbursement negotiations and volume-based procurement continue to drive down drug prices, while significantly improving treatment accessibility and accelerating market uptake. From a competitive standpoint, the launch of multiple new DAA combination regimens is intensifying market competition. Therefore, the future market performance of danoprevir sodium will depend on its clinical positioning within combination therapies, the accumulation of real-world efficacy and safety data, and its overall competitiveness in pricing, distribution channels, and reimbursement coverage.
LP Information, Inc. (LPI) ' newest research report, the ?Danoprevir Sodium Industry Forecast? looks at past sales and reviews total world Danoprevir Sodium sales in 2025, providing a comprehensive analysis by region and market sector of projected Danoprevir Sodium sales for 2026 through 2032. With Danoprevir Sodium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Danoprevir Sodium industry.
This Insight Report provides a comprehensive analysis of the global Danoprevir Sodium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Danoprevir Sodium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Danoprevir Sodium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Danoprevir Sodium and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Danoprevir Sodium.
This report presents a comprehensive overview, market shares, and growth opportunities of Danoprevir Sodium market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Danoprevir Sodium market?
What factors are driving Danoprevir Sodium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Danoprevir Sodium market opportunities vary by end market size?
How does Danoprevir Sodium break out by Type, by Application?
In 2025, global Danoprevir Sodium production reached approximately 23,000 units.Danoprevir Sodium (brand name: Ganovo), independently developed by Ascletis Pharma, is China?s first domestically originated Class 1 chemical anti?hepatitis C virus (HCV) drug. Classified as a new?generation NS3/4A protease inhibitor among direct?acting antivirals (DAAs), it is an achievement of the national Major New Drug Creation Project. Approved by the NMPA in June 2018, it is indicated for the targeted antiviral treatment of chronic hepatitis C.
Danoprevir Sodium is an NS3/4A protease inhibitor targeting hepatitis C virus (HCV), typically used in combination with other direct-acting antivirals (DAAs), and has an established application base in China?s HCV antiviral treatment market. With the continued advancement of the national ?hepatitis C elimination? strategy and improvements in screening and diagnosis rates, treatment demand is being progressively released, providing a stable market opportunity for this drug.
From a competitive landscape perspective, pan-genotypic DAA regimens centered on Sofosbuvir, along with imported originator products, still dominate the market. However, danoprevir sodium, leveraging its domestic R&D background, pricing advantages, and value in specific combination regimens, demonstrates a certain level of competitiveness in selected patient populations.
On the policy side, national reimbursement negotiations and volume-based procurement continue to drive down drug prices, while significantly improving treatment accessibility and accelerating market uptake. From a competitive standpoint, the launch of multiple new DAA combination regimens is intensifying market competition. Therefore, the future market performance of danoprevir sodium will depend on its clinical positioning within combination therapies, the accumulation of real-world efficacy and safety data, and its overall competitiveness in pricing, distribution channels, and reimbursement coverage.
LP Information, Inc. (LPI) ' newest research report, the ?Danoprevir Sodium Industry Forecast? looks at past sales and reviews total world Danoprevir Sodium sales in 2025, providing a comprehensive analysis by region and market sector of projected Danoprevir Sodium sales for 2026 through 2032. With Danoprevir Sodium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Danoprevir Sodium industry.
This Insight Report provides a comprehensive analysis of the global Danoprevir Sodium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Danoprevir Sodium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Danoprevir Sodium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Danoprevir Sodium and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Danoprevir Sodium.
This report presents a comprehensive overview, market shares, and growth opportunities of Danoprevir Sodium market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 100 mg/tablet
- 200 mg/tablet
- Tablet
- Capsule
- Immediate-release (IR)
- Sustained-release (SR)
- Treatment-na?ve Adult Patients With Chronic hepatitis C
- Non-cirrhotic Population
- Confirmed HCV Genotype 1b Infection
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ascletis Pharma
What is the 10-year outlook for the global Danoprevir Sodium market?
What factors are driving Danoprevir Sodium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Danoprevir Sodium market opportunities vary by end market size?
How does Danoprevir Sodium break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Danoprevir Sodium Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Danoprevir Sodium by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Danoprevir Sodium by Country/Region, 2021, 2025 & 2032
2.2 Danoprevir Sodium Segment by Type
2.2.1 100 mg/tablet
2.2.2 200 mg/tablet
2.2.3 Danoprevir Sodium Sales by Type
2.2.3.1 Global Danoprevir Sodium Sales Market Share by Type (2021-2026)
2.2.3.2 Global Danoprevir Sodium Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Danoprevir Sodium Sale Price by Type (2021-2026)
2.3 Danoprevir Sodium Segment by Dosage form
2.3.1 Tablet
2.3.2 Capsule
2.3.3 Danoprevir Sodium Sales by Dosage form
2.3.3.1 Global Danoprevir Sodium Sales Market Share by Dosage form (2021-2026)
2.3.3.2 Global Danoprevir Sodium Revenue and Market Share by Dosage form (2021-2026)
2.3.3.3 Global Danoprevir Sodium Sale Price by Dosage form (2021-2026)
2.4 Danoprevir Sodium Segment by Release type
2.4.1 Immediate-release (IR)
2.4.2 Sustained-release (SR)
2.4.3 Danoprevir Sodium Sales by Release type
2.4.3.1 Global Danoprevir Sodium Sales Market Share by Release type (2021-2026)
2.4.3.2 Global Danoprevir Sodium Revenue and Market Share by Release type (2021-2026)
2.4.3.3 Global Danoprevir Sodium Sale Price by Release type (2021-2026)
2.5 Danoprevir Sodium Segment by Application
2.5.1 Treatment-na?ve Adult Patients With Chronic hepatitis C
2.5.2 Non-cirrhotic Population
2.5.3 Confirmed HCV Genotype 1b Infection
2.5.4 Others
2.5.5 Danoprevir Sodium Sales by Application
2.5.5.1 Global Danoprevir Sodium Sale Market Share by Application (2021-2026)
2.5.5.2 Global Danoprevir Sodium Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Danoprevir Sodium Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Danoprevir Sodium Breakdown Data by Company
3.1.1 Global Danoprevir Sodium Annual Sales by Company (2021-2026)
3.1.2 Global Danoprevir Sodium Sales Market Share by Company (2021-2026)
3.2 Global Danoprevir Sodium Annual Revenue by Company (2021-2026)
3.2.1 Global Danoprevir Sodium Revenue by Company (2021-2026)
3.2.2 Global Danoprevir Sodium Revenue Market Share by Company (2021-2026)
3.3 Global Danoprevir Sodium Sale Price by Company
3.4 Key Manufacturers Danoprevir Sodium Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Danoprevir Sodium Product Location Distribution
3.4.2 Players Danoprevir Sodium Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DANOPREVIR SODIUM BY GEOGRAPHIC REGION
4.1 World Historic Danoprevir Sodium Market Size by Geographic Region (2021-2026)
4.1.1 Global Danoprevir Sodium Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Danoprevir Sodium Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Danoprevir Sodium Market Size by Country/Region (2021-2026)
4.2.1 Global Danoprevir Sodium Annual Sales by Country/Region (2021-2026)
4.2.2 Global Danoprevir Sodium Annual Revenue by Country/Region (2021-2026)
4.3 Americas Danoprevir Sodium Sales Growth
4.4 APAC Danoprevir Sodium Sales Growth
4.5 Europe Danoprevir Sodium Sales Growth
4.6 Middle East & Africa Danoprevir Sodium Sales Growth
5 AMERICAS
5.1 Americas Danoprevir Sodium Sales by Country
5.1.1 Americas Danoprevir Sodium Sales by Country (2021-2026)
5.1.2 Americas Danoprevir Sodium Revenue by Country (2021-2026)
5.2 Americas Danoprevir Sodium Sales by Type (2021-2026)
5.3 Americas Danoprevir Sodium Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Danoprevir Sodium Sales by Region
6.1.1 APAC Danoprevir Sodium Sales by Region (2021-2026)
6.1.2 APAC Danoprevir Sodium Revenue by Region (2021-2026)
6.2 APAC Danoprevir Sodium Sales by Type (2021-2026)
6.3 APAC Danoprevir Sodium Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Danoprevir Sodium by Country
7.1.1 Europe Danoprevir Sodium Sales by Country (2021-2026)
7.1.2 Europe Danoprevir Sodium Revenue by Country (2021-2026)
7.2 Europe Danoprevir Sodium Sales by Type (2021-2026)
7.3 Europe Danoprevir Sodium Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Danoprevir Sodium by Country
8.1.1 Middle East & Africa Danoprevir Sodium Sales by Country (2021-2026)
8.1.2 Middle East & Africa Danoprevir Sodium Revenue by Country (2021-2026)
8.2 Middle East & Africa Danoprevir Sodium Sales by Type (2021-2026)
8.3 Middle East & Africa Danoprevir Sodium Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Danoprevir Sodium
10.3 Manufacturing Process Analysis of Danoprevir Sodium
10.4 Industry Chain Structure of Danoprevir Sodium
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Danoprevir Sodium Distributors
11.3 Danoprevir Sodium Customer
12 WORLD FORECAST REVIEW FOR DANOPREVIR SODIUM BY GEOGRAPHIC REGION
12.1 Global Danoprevir Sodium Market Size Forecast by Region
12.1.1 Global Danoprevir Sodium Forecast by Region (2027-2032)
12.1.2 Global Danoprevir Sodium Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Danoprevir Sodium Forecast by Type (2027-2032)
12.7 Global Danoprevir Sodium Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Ascletis Pharma
13.1.1 Ascletis Pharma Company Information
13.1.2 Ascletis Pharma Danoprevir Sodium Product Portfolios and Specifications
13.1.3 Ascletis Pharma Danoprevir Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Ascletis Pharma Main Business Overview
13.1.5 Ascletis Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Danoprevir Sodium Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Danoprevir Sodium by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Danoprevir Sodium by Country/Region, 2021, 2025 & 2032
2.2 Danoprevir Sodium Segment by Type
2.2.1 100 mg/tablet
2.2.2 200 mg/tablet
2.2.3 Danoprevir Sodium Sales by Type
2.2.3.1 Global Danoprevir Sodium Sales Market Share by Type (2021-2026)
2.2.3.2 Global Danoprevir Sodium Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Danoprevir Sodium Sale Price by Type (2021-2026)
2.3 Danoprevir Sodium Segment by Dosage form
2.3.1 Tablet
2.3.2 Capsule
2.3.3 Danoprevir Sodium Sales by Dosage form
2.3.3.1 Global Danoprevir Sodium Sales Market Share by Dosage form (2021-2026)
2.3.3.2 Global Danoprevir Sodium Revenue and Market Share by Dosage form (2021-2026)
2.3.3.3 Global Danoprevir Sodium Sale Price by Dosage form (2021-2026)
2.4 Danoprevir Sodium Segment by Release type
2.4.1 Immediate-release (IR)
2.4.2 Sustained-release (SR)
2.4.3 Danoprevir Sodium Sales by Release type
2.4.3.1 Global Danoprevir Sodium Sales Market Share by Release type (2021-2026)
2.4.3.2 Global Danoprevir Sodium Revenue and Market Share by Release type (2021-2026)
2.4.3.3 Global Danoprevir Sodium Sale Price by Release type (2021-2026)
2.5 Danoprevir Sodium Segment by Application
2.5.1 Treatment-na?ve Adult Patients With Chronic hepatitis C
2.5.2 Non-cirrhotic Population
2.5.3 Confirmed HCV Genotype 1b Infection
2.5.4 Others
2.5.5 Danoprevir Sodium Sales by Application
2.5.5.1 Global Danoprevir Sodium Sale Market Share by Application (2021-2026)
2.5.5.2 Global Danoprevir Sodium Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Danoprevir Sodium Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Danoprevir Sodium Breakdown Data by Company
3.1.1 Global Danoprevir Sodium Annual Sales by Company (2021-2026)
3.1.2 Global Danoprevir Sodium Sales Market Share by Company (2021-2026)
3.2 Global Danoprevir Sodium Annual Revenue by Company (2021-2026)
3.2.1 Global Danoprevir Sodium Revenue by Company (2021-2026)
3.2.2 Global Danoprevir Sodium Revenue Market Share by Company (2021-2026)
3.3 Global Danoprevir Sodium Sale Price by Company
3.4 Key Manufacturers Danoprevir Sodium Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Danoprevir Sodium Product Location Distribution
3.4.2 Players Danoprevir Sodium Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DANOPREVIR SODIUM BY GEOGRAPHIC REGION
4.1 World Historic Danoprevir Sodium Market Size by Geographic Region (2021-2026)
4.1.1 Global Danoprevir Sodium Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Danoprevir Sodium Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Danoprevir Sodium Market Size by Country/Region (2021-2026)
4.2.1 Global Danoprevir Sodium Annual Sales by Country/Region (2021-2026)
4.2.2 Global Danoprevir Sodium Annual Revenue by Country/Region (2021-2026)
4.3 Americas Danoprevir Sodium Sales Growth
4.4 APAC Danoprevir Sodium Sales Growth
4.5 Europe Danoprevir Sodium Sales Growth
4.6 Middle East & Africa Danoprevir Sodium Sales Growth
5 AMERICAS
5.1 Americas Danoprevir Sodium Sales by Country
5.1.1 Americas Danoprevir Sodium Sales by Country (2021-2026)
5.1.2 Americas Danoprevir Sodium Revenue by Country (2021-2026)
5.2 Americas Danoprevir Sodium Sales by Type (2021-2026)
5.3 Americas Danoprevir Sodium Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Danoprevir Sodium Sales by Region
6.1.1 APAC Danoprevir Sodium Sales by Region (2021-2026)
6.1.2 APAC Danoprevir Sodium Revenue by Region (2021-2026)
6.2 APAC Danoprevir Sodium Sales by Type (2021-2026)
6.3 APAC Danoprevir Sodium Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Danoprevir Sodium by Country
7.1.1 Europe Danoprevir Sodium Sales by Country (2021-2026)
7.1.2 Europe Danoprevir Sodium Revenue by Country (2021-2026)
7.2 Europe Danoprevir Sodium Sales by Type (2021-2026)
7.3 Europe Danoprevir Sodium Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Danoprevir Sodium by Country
8.1.1 Middle East & Africa Danoprevir Sodium Sales by Country (2021-2026)
8.1.2 Middle East & Africa Danoprevir Sodium Revenue by Country (2021-2026)
8.2 Middle East & Africa Danoprevir Sodium Sales by Type (2021-2026)
8.3 Middle East & Africa Danoprevir Sodium Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Danoprevir Sodium
10.3 Manufacturing Process Analysis of Danoprevir Sodium
10.4 Industry Chain Structure of Danoprevir Sodium
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Danoprevir Sodium Distributors
11.3 Danoprevir Sodium Customer
12 WORLD FORECAST REVIEW FOR DANOPREVIR SODIUM BY GEOGRAPHIC REGION
12.1 Global Danoprevir Sodium Market Size Forecast by Region
12.1.1 Global Danoprevir Sodium Forecast by Region (2027-2032)
12.1.2 Global Danoprevir Sodium Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Danoprevir Sodium Forecast by Type (2027-2032)
12.7 Global Danoprevir Sodium Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Ascletis Pharma
13.1.1 Ascletis Pharma Company Information
13.1.2 Ascletis Pharma Danoprevir Sodium Product Portfolios and Specifications
13.1.3 Ascletis Pharma Danoprevir Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Ascletis Pharma Main Business Overview
13.1.5 Ascletis Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Danoprevir Sodium Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Danoprevir Sodium Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 100 mg/tablet
Table 4. Major Players of 200 mg/tablet
Table 5. Global Danoprevir Sodium Sales by Type (2021-2026) & (Units)
Table 6. Global Danoprevir Sodium Sales Market Share by Type (2021-2026)
Table 7. Global Danoprevir Sodium Revenue by Type (2021-2026) & ($ million)
Table 8. Global Danoprevir Sodium Revenue Market Share by Type (2021-2026)
Table 9. Global Danoprevir Sodium Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players ofTablet
Table 11. Major Players of Capsule
Table 12. Global Danoprevir Sodium Sales by Dosage form (2021-2026) & (Units)
Table 13. Global Danoprevir Sodium Sales Market Share by Dosage form (2021-2026)
Table 14. Global Danoprevir Sodium Revenue by Dosage form (2021-2026) & ($ million)
Table 15. Global Danoprevir Sodium Revenue Market Share by Dosage form (2021-2026)
Table 16. Global Danoprevir Sodium Sale Price by Dosage form (2021-2026) & (US$/Unit)
Table 17. Major Players of Immediate-release (IR)
Table 18. Major Players of Sustained-release (SR)
Table 19. Global Danoprevir Sodium Sales by Release type (2021-2026) & (Units)
Table 20. Global Danoprevir Sodium Sales Market Share by Release type (2021-2026)
Table 21. Global Danoprevir Sodium Revenue by Release type (2021-2026) & ($ million)
Table 22. Global Danoprevir Sodium Revenue Market Share by Release type (2021-2026)
Table 23. Global Danoprevir Sodium Sale Price by Release type (2021-2026) & (US$/Unit)
Table 24. Global Danoprevir Sodium Sale by Application (2021-2026) & (Units)
Table 25. Global Danoprevir Sodium Sale Market Share by Application (2021-2026)
Table 26. Global Danoprevir Sodium Revenue by Application (2021-2026) & ($ million)
Table 27. Global Danoprevir Sodium Revenue Market Share by Application (2021-2026)
Table 28. Global Danoprevir Sodium Sale Price by Application (2021-2026) & (US$/Unit)
Table 29. Global Danoprevir Sodium Sales by Company (2021-2026) & (Units)
Table 30. Global Danoprevir Sodium Sales Market Share by Company (2021-2026)
Table 31. Global Danoprevir Sodium Revenue by Company (2021-2026) & ($ millions)
Table 32. Global Danoprevir Sodium Revenue Market Share by Company (2021-2026)
Table 33. Global Danoprevir Sodium Sale Price by Company (2021-2026) & (US$/Unit)
Table 34. Key Manufacturers Danoprevir Sodium Producing Area Distribution and Sales Area
Table 35. Players Danoprevir Sodium Products Offered
Table 36. Danoprevir Sodium Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 37. New Products and Potential Entrants
Table 38. Market M&A Activity & Strategy
Table 39. Global Danoprevir Sodium Sales by Geographic Region (2021-2026) & (Units)
Table 40. Global Danoprevir Sodium Sales Market Share Geographic Region (2021-2026)
Table 41. Global Danoprevir Sodium Revenue by Geographic Region (2021-2026) & ($ millions)
Table 42. Global Danoprevir Sodium Revenue Market Share by Geographic Region (2021-2026)
Table 43. Global Danoprevir Sodium Sales by Country/Region (2021-2026) & (Units)
Table 44. Global Danoprevir Sodium Sales Market Share by Country/Region (2021-2026)
Table 45. Global Danoprevir Sodium Revenue by Country/Region (2021-2026) & ($ millions)
Table 46. Global Danoprevir Sodium Revenue Market Share by Country/Region (2021-2026)
Table 47. Americas Danoprevir Sodium Sales by Country (2021-2026) & (Units)
Table 48. Americas Danoprevir Sodium Sales Market Share by Country (2021-2026)
Table 49. Americas Danoprevir Sodium Revenue by Country (2021-2026) & ($ millions)
Table 50. Americas Danoprevir Sodium Sales by Type (2021-2026) & (Units)
Table 51. Americas Danoprevir Sodium Sales by Application (2021-2026) & (Units)
Table 52. APAC Danoprevir Sodium Sales by Region (2021-2026) & (Units)
Table 53. APAC Danoprevir Sodium Sales Market Share by Region (2021-2026)
Table 54. APAC Danoprevir Sodium Revenue by Region (2021-2026) & ($ millions)
Table 55. APAC Danoprevir Sodium Sales by Type (2021-2026) & (Units)
Table 56. APAC Danoprevir Sodium Sales by Application (2021-2026) & (Units)
Table 57. Europe Danoprevir Sodium Sales by Country (2021-2026) & (Units)
Table 58. Europe Danoprevir Sodium Revenue by Country (2021-2026) & ($ millions)
Table 59. Europe Danoprevir Sodium Sales by Type (2021-2026) & (Units)
Table 60. Europe Danoprevir Sodium Sales by Application (2021-2026) & (Units)
Table 61. Middle East & Africa Danoprevir Sodium Sales by Country (2021-2026) & (Units)
Table 62. Middle East & Africa Danoprevir Sodium Revenue Market Share by Country (2021-2026)
Table 63. Middle East & Africa Danoprevir Sodium Sales by Type (2021-2026) & (Units)
Table 64. Middle East & Africa Danoprevir Sodium Sales by Application (2021-2026) & (Units)
Table 65. Key Market Drivers & Growth Opportunities of Danoprevir Sodium
Table 66. Key Market Challenges & Risks of Danoprevir Sodium
Table 67. Key Industry Trends of Danoprevir Sodium
Table 68. Danoprevir Sodium Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Danoprevir Sodium Distributors List
Table 71. Danoprevir Sodium Customer List
Table 72. Global Danoprevir Sodium Sales Forecast by Region (2027-2032) & (Units)
Table 73. Global Danoprevir Sodium Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Americas Danoprevir Sodium Sales Forecast by Country (2027-2032) & (Units)
Table 75. Americas Danoprevir Sodium Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. APAC Danoprevir Sodium Sales Forecast by Region (2027-2032) & (Units)
Table 77. APAC Danoprevir Sodium Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Europe Danoprevir Sodium Sales Forecast by Country (2027-2032) & (Units)
Table 79. Europe Danoprevir Sodium Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Middle East & Africa Danoprevir Sodium Sales Forecast by Country (2027-2032) & (Units)
Table 81. Middle East & Africa Danoprevir Sodium Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Global Danoprevir Sodium Sales Forecast by Type (2027-2032) & (Units)
Table 83. Global Danoprevir Sodium Revenue Forecast by Type (2027-2032) & ($ millions)
Table 84. Global Danoprevir Sodium Sales Forecast by Application (2027-2032) & (Units)
Table 85. Global Danoprevir Sodium Revenue Forecast by Application (2027-2032) & ($ millions)
Table 86. Ascletis Pharma Basic Information, Danoprevir Sodium Manufacturing Base, Sales Area and Its Competitors
Table 87. Ascletis Pharma Danoprevir Sodium Product Portfolios and Specifications
Table 88. Ascletis Pharma Danoprevir Sodium Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Ascletis Pharma Main Business
Table 90. Ascletis Pharma Latest Developments
Table 1. Danoprevir Sodium Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Danoprevir Sodium Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 100 mg/tablet
Table 4. Major Players of 200 mg/tablet
Table 5. Global Danoprevir Sodium Sales by Type (2021-2026) & (Units)
Table 6. Global Danoprevir Sodium Sales Market Share by Type (2021-2026)
Table 7. Global Danoprevir Sodium Revenue by Type (2021-2026) & ($ million)
Table 8. Global Danoprevir Sodium Revenue Market Share by Type (2021-2026)
Table 9. Global Danoprevir Sodium Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players ofTablet
Table 11. Major Players of Capsule
Table 12. Global Danoprevir Sodium Sales by Dosage form (2021-2026) & (Units)
Table 13. Global Danoprevir Sodium Sales Market Share by Dosage form (2021-2026)
Table 14. Global Danoprevir Sodium Revenue by Dosage form (2021-2026) & ($ million)
Table 15. Global Danoprevir Sodium Revenue Market Share by Dosage form (2021-2026)
Table 16. Global Danoprevir Sodium Sale Price by Dosage form (2021-2026) & (US$/Unit)
Table 17. Major Players of Immediate-release (IR)
Table 18. Major Players of Sustained-release (SR)
Table 19. Global Danoprevir Sodium Sales by Release type (2021-2026) & (Units)
Table 20. Global Danoprevir Sodium Sales Market Share by Release type (2021-2026)
Table 21. Global Danoprevir Sodium Revenue by Release type (2021-2026) & ($ million)
Table 22. Global Danoprevir Sodium Revenue Market Share by Release type (2021-2026)
Table 23. Global Danoprevir Sodium Sale Price by Release type (2021-2026) & (US$/Unit)
Table 24. Global Danoprevir Sodium Sale by Application (2021-2026) & (Units)
Table 25. Global Danoprevir Sodium Sale Market Share by Application (2021-2026)
Table 26. Global Danoprevir Sodium Revenue by Application (2021-2026) & ($ million)
Table 27. Global Danoprevir Sodium Revenue Market Share by Application (2021-2026)
Table 28. Global Danoprevir Sodium Sale Price by Application (2021-2026) & (US$/Unit)
Table 29. Global Danoprevir Sodium Sales by Company (2021-2026) & (Units)
Table 30. Global Danoprevir Sodium Sales Market Share by Company (2021-2026)
Table 31. Global Danoprevir Sodium Revenue by Company (2021-2026) & ($ millions)
Table 32. Global Danoprevir Sodium Revenue Market Share by Company (2021-2026)
Table 33. Global Danoprevir Sodium Sale Price by Company (2021-2026) & (US$/Unit)
Table 34. Key Manufacturers Danoprevir Sodium Producing Area Distribution and Sales Area
Table 35. Players Danoprevir Sodium Products Offered
Table 36. Danoprevir Sodium Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 37. New Products and Potential Entrants
Table 38. Market M&A Activity & Strategy
Table 39. Global Danoprevir Sodium Sales by Geographic Region (2021-2026) & (Units)
Table 40. Global Danoprevir Sodium Sales Market Share Geographic Region (2021-2026)
Table 41. Global Danoprevir Sodium Revenue by Geographic Region (2021-2026) & ($ millions)
Table 42. Global Danoprevir Sodium Revenue Market Share by Geographic Region (2021-2026)
Table 43. Global Danoprevir Sodium Sales by Country/Region (2021-2026) & (Units)
Table 44. Global Danoprevir Sodium Sales Market Share by Country/Region (2021-2026)
Table 45. Global Danoprevir Sodium Revenue by Country/Region (2021-2026) & ($ millions)
Table 46. Global Danoprevir Sodium Revenue Market Share by Country/Region (2021-2026)
Table 47. Americas Danoprevir Sodium Sales by Country (2021-2026) & (Units)
Table 48. Americas Danoprevir Sodium Sales Market Share by Country (2021-2026)
Table 49. Americas Danoprevir Sodium Revenue by Country (2021-2026) & ($ millions)
Table 50. Americas Danoprevir Sodium Sales by Type (2021-2026) & (Units)
Table 51. Americas Danoprevir Sodium Sales by Application (2021-2026) & (Units)
Table 52. APAC Danoprevir Sodium Sales by Region (2021-2026) & (Units)
Table 53. APAC Danoprevir Sodium Sales Market Share by Region (2021-2026)
Table 54. APAC Danoprevir Sodium Revenue by Region (2021-2026) & ($ millions)
Table 55. APAC Danoprevir Sodium Sales by Type (2021-2026) & (Units)
Table 56. APAC Danoprevir Sodium Sales by Application (2021-2026) & (Units)
Table 57. Europe Danoprevir Sodium Sales by Country (2021-2026) & (Units)
Table 58. Europe Danoprevir Sodium Revenue by Country (2021-2026) & ($ millions)
Table 59. Europe Danoprevir Sodium Sales by Type (2021-2026) & (Units)
Table 60. Europe Danoprevir Sodium Sales by Application (2021-2026) & (Units)
Table 61. Middle East & Africa Danoprevir Sodium Sales by Country (2021-2026) & (Units)
Table 62. Middle East & Africa Danoprevir Sodium Revenue Market Share by Country (2021-2026)
Table 63. Middle East & Africa Danoprevir Sodium Sales by Type (2021-2026) & (Units)
Table 64. Middle East & Africa Danoprevir Sodium Sales by Application (2021-2026) & (Units)
Table 65. Key Market Drivers & Growth Opportunities of Danoprevir Sodium
Table 66. Key Market Challenges & Risks of Danoprevir Sodium
Table 67. Key Industry Trends of Danoprevir Sodium
Table 68. Danoprevir Sodium Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Danoprevir Sodium Distributors List
Table 71. Danoprevir Sodium Customer List
Table 72. Global Danoprevir Sodium Sales Forecast by Region (2027-2032) & (Units)
Table 73. Global Danoprevir Sodium Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Americas Danoprevir Sodium Sales Forecast by Country (2027-2032) & (Units)
Table 75. Americas Danoprevir Sodium Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. APAC Danoprevir Sodium Sales Forecast by Region (2027-2032) & (Units)
Table 77. APAC Danoprevir Sodium Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Europe Danoprevir Sodium Sales Forecast by Country (2027-2032) & (Units)
Table 79. Europe Danoprevir Sodium Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Middle East & Africa Danoprevir Sodium Sales Forecast by Country (2027-2032) & (Units)
Table 81. Middle East & Africa Danoprevir Sodium Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Global Danoprevir Sodium Sales Forecast by Type (2027-2032) & (Units)
Table 83. Global Danoprevir Sodium Revenue Forecast by Type (2027-2032) & ($ millions)
Table 84. Global Danoprevir Sodium Sales Forecast by Application (2027-2032) & (Units)
Table 85. Global Danoprevir Sodium Revenue Forecast by Application (2027-2032) & ($ millions)
Table 86. Ascletis Pharma Basic Information, Danoprevir Sodium Manufacturing Base, Sales Area and Its Competitors
Table 87. Ascletis Pharma Danoprevir Sodium Product Portfolios and Specifications
Table 88. Ascletis Pharma Danoprevir Sodium Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Ascletis Pharma Main Business
Table 90. Ascletis Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Danoprevir Sodium
Figure 2. Danoprevir Sodium Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Danoprevir Sodium Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Danoprevir Sodium Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Danoprevir Sodium Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Danoprevir Sodium Sales Market Share by Country/Region (2025)
Figure 10. Danoprevir Sodium Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 100 mg/tablet
Figure 12. Product Picture of 200 mg/tablet
Figure 13. Global Danoprevir Sodium Sales Market Share by Type in 2026
Figure 14. Global Danoprevir Sodium Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture ofTablet
Figure 16. Product Picture of Capsule
Figure 17. Global Danoprevir Sodium Sales Market Share by Dosage form in 2026
Figure 18. Global Danoprevir Sodium Revenue Market Share by Dosage form (2021-2026)
Figure 19. Product Picture of Immediate-release (IR)
Figure 20. Product Picture of Sustained-release (SR)
Figure 21. Global Danoprevir Sodium Sales Market Share by Release type in 2026
Figure 22. Global Danoprevir Sodium Revenue Market Share by Release type (2021-2026)
Figure 23. Danoprevir Sodium Consumed in Treatment-na?ve Adult Patients With Chronic hepatitis C
Figure 24. Global Danoprevir Sodium Market: Treatment-na?ve Adult Patients With Chronic hepatitis C (2021-2026) & (Units)
Figure 25. Danoprevir Sodium Consumed in Non-cirrhotic Population
Figure 26. Global Danoprevir Sodium Market: Non-cirrhotic Population (2021-2026) & (Units)
Figure 27. Danoprevir Sodium Consumed in Confirmed HCV Genotype 1b Infection
Figure 28. Global Danoprevir Sodium Market: Confirmed HCV Genotype 1b Infection (2021-2026) & (Units)
Figure 29. Danoprevir Sodium Consumed in Others
Figure 30. Global Danoprevir Sodium Market: Others (2021-2026) & (Units)
Figure 31. Global Danoprevir Sodium Sale Market Share by Application (2025)
Figure 32. Global Danoprevir Sodium Revenue Market Share by Application in 2025
Figure 33. Danoprevir Sodium Sales by Company in 2025 (Units)
Figure 34. Global Danoprevir Sodium Sales Market Share by Company in 2025
Figure 35. Danoprevir Sodium Revenue by Company in 2025 ($ millions)
Figure 36. Global Danoprevir Sodium Revenue Market Share by Company in 2025
Figure 37. Global Danoprevir Sodium Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Danoprevir Sodium Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Danoprevir Sodium Sales 2021-2026 (Units)
Figure 40. Americas Danoprevir Sodium Revenue 2021-2026 ($ millions)
Figure 41. APAC Danoprevir Sodium Sales 2021-2026 (Units)
Figure 42. APAC Danoprevir Sodium Revenue 2021-2026 ($ millions)
Figure 43. Europe Danoprevir Sodium Sales 2021-2026 (Units)
Figure 44. Europe Danoprevir Sodium Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Danoprevir Sodium Sales 2021-2026 (Units)
Figure 46. Middle East & Africa Danoprevir Sodium Revenue 2021-2026 ($ millions)
Figure 47. Americas Danoprevir Sodium Sales Market Share by Country in 2025
Figure 48. Americas Danoprevir Sodium Revenue Market Share by Country (2021-2026)
Figure 49. Americas Danoprevir Sodium Sales Market Share by Type (2021-2026)
Figure 50. Americas Danoprevir Sodium Sales Market Share by Application (2021-2026)
Figure 51. United States Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Danoprevir Sodium Sales Market Share by Region in 2025
Figure 56. APAC Danoprevir Sodium Revenue Market Share by Region (2021-2026)
Figure 57. APAC Danoprevir Sodium Sales Market Share by Type (2021-2026)
Figure 58. APAC Danoprevir Sodium Sales Market Share by Application (2021-2026)
Figure 59. China Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 63. India Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Danoprevir Sodium Sales Market Share by Country in 2025
Figure 67. Europe Danoprevir Sodium Revenue Market Share by Country (2021-2026)
Figure 68. Europe Danoprevir Sodium Sales Market Share by Type (2021-2026)
Figure 69. Europe Danoprevir Sodium Sales Market Share by Application (2021-2026)
Figure 70. Germany Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 71. France Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Danoprevir Sodium Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Danoprevir Sodium Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Danoprevir Sodium Sales Market Share by Application (2021-2026)
Figure 78. Egypt Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Danoprevir Sodium in 2026
Figure 84. Manufacturing Process Analysis of Danoprevir Sodium
Figure 85. Industry Chain Structure of Danoprevir Sodium
Figure 86. Channels of Distribution
Figure 87. Global Danoprevir Sodium Sales Market Forecast by Region (2027-2032)
Figure 88. Global Danoprevir Sodium Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Danoprevir Sodium Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Danoprevir Sodium Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Danoprevir Sodium Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Danoprevir Sodium Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Danoprevir Sodium
Figure 2. Danoprevir Sodium Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Danoprevir Sodium Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Danoprevir Sodium Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Danoprevir Sodium Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Danoprevir Sodium Sales Market Share by Country/Region (2025)
Figure 10. Danoprevir Sodium Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 100 mg/tablet
Figure 12. Product Picture of 200 mg/tablet
Figure 13. Global Danoprevir Sodium Sales Market Share by Type in 2026
Figure 14. Global Danoprevir Sodium Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture ofTablet
Figure 16. Product Picture of Capsule
Figure 17. Global Danoprevir Sodium Sales Market Share by Dosage form in 2026
Figure 18. Global Danoprevir Sodium Revenue Market Share by Dosage form (2021-2026)
Figure 19. Product Picture of Immediate-release (IR)
Figure 20. Product Picture of Sustained-release (SR)
Figure 21. Global Danoprevir Sodium Sales Market Share by Release type in 2026
Figure 22. Global Danoprevir Sodium Revenue Market Share by Release type (2021-2026)
Figure 23. Danoprevir Sodium Consumed in Treatment-na?ve Adult Patients With Chronic hepatitis C
Figure 24. Global Danoprevir Sodium Market: Treatment-na?ve Adult Patients With Chronic hepatitis C (2021-2026) & (Units)
Figure 25. Danoprevir Sodium Consumed in Non-cirrhotic Population
Figure 26. Global Danoprevir Sodium Market: Non-cirrhotic Population (2021-2026) & (Units)
Figure 27. Danoprevir Sodium Consumed in Confirmed HCV Genotype 1b Infection
Figure 28. Global Danoprevir Sodium Market: Confirmed HCV Genotype 1b Infection (2021-2026) & (Units)
Figure 29. Danoprevir Sodium Consumed in Others
Figure 30. Global Danoprevir Sodium Market: Others (2021-2026) & (Units)
Figure 31. Global Danoprevir Sodium Sale Market Share by Application (2025)
Figure 32. Global Danoprevir Sodium Revenue Market Share by Application in 2025
Figure 33. Danoprevir Sodium Sales by Company in 2025 (Units)
Figure 34. Global Danoprevir Sodium Sales Market Share by Company in 2025
Figure 35. Danoprevir Sodium Revenue by Company in 2025 ($ millions)
Figure 36. Global Danoprevir Sodium Revenue Market Share by Company in 2025
Figure 37. Global Danoprevir Sodium Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Danoprevir Sodium Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Danoprevir Sodium Sales 2021-2026 (Units)
Figure 40. Americas Danoprevir Sodium Revenue 2021-2026 ($ millions)
Figure 41. APAC Danoprevir Sodium Sales 2021-2026 (Units)
Figure 42. APAC Danoprevir Sodium Revenue 2021-2026 ($ millions)
Figure 43. Europe Danoprevir Sodium Sales 2021-2026 (Units)
Figure 44. Europe Danoprevir Sodium Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Danoprevir Sodium Sales 2021-2026 (Units)
Figure 46. Middle East & Africa Danoprevir Sodium Revenue 2021-2026 ($ millions)
Figure 47. Americas Danoprevir Sodium Sales Market Share by Country in 2025
Figure 48. Americas Danoprevir Sodium Revenue Market Share by Country (2021-2026)
Figure 49. Americas Danoprevir Sodium Sales Market Share by Type (2021-2026)
Figure 50. Americas Danoprevir Sodium Sales Market Share by Application (2021-2026)
Figure 51. United States Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Danoprevir Sodium Sales Market Share by Region in 2025
Figure 56. APAC Danoprevir Sodium Revenue Market Share by Region (2021-2026)
Figure 57. APAC Danoprevir Sodium Sales Market Share by Type (2021-2026)
Figure 58. APAC Danoprevir Sodium Sales Market Share by Application (2021-2026)
Figure 59. China Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 63. India Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Danoprevir Sodium Sales Market Share by Country in 2025
Figure 67. Europe Danoprevir Sodium Revenue Market Share by Country (2021-2026)
Figure 68. Europe Danoprevir Sodium Sales Market Share by Type (2021-2026)
Figure 69. Europe Danoprevir Sodium Sales Market Share by Application (2021-2026)
Figure 70. Germany Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 71. France Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Danoprevir Sodium Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Danoprevir Sodium Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Danoprevir Sodium Sales Market Share by Application (2021-2026)
Figure 78. Egypt Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Danoprevir Sodium Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Danoprevir Sodium in 2026
Figure 84. Manufacturing Process Analysis of Danoprevir Sodium
Figure 85. Industry Chain Structure of Danoprevir Sodium
Figure 86. Channels of Distribution
Figure 87. Global Danoprevir Sodium Sales Market Forecast by Region (2027-2032)
Figure 88. Global Danoprevir Sodium Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Danoprevir Sodium Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Danoprevir Sodium Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Danoprevir Sodium Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Danoprevir Sodium Revenue Market Share Forecast by Application (2027-2032)
